Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: Comparison of the conventional enzyme immunoassay and two modified methods

American Journal of Gastroenterology

Volumn 91, Issue 7, 1996, Pages 1380-1383

  Nomura, Fumio ^a   Ishijima, Michikuni ^b   Horikoshi, Akira ^b   Nakai, Toshiaki ^b   Ohnishi, Kunihiko ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; AVIDIN; BIOTIN; DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER SIZE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY CANCER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; PROTHROMBIN; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0030018852     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986;6:729-38.
2. Alpert E, Hershberg R, Schur PH, et al. Alpha-fetoprotein in human hepatoma: Improved detection in serum, and a quantitative studies using a new sensitive technique. Gastroenterology 1971;61:137-43.
3. Chen DS, Song JL. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977;40:779-83.
4. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 1989;64:1700-7.
5. Weitz LC, Liebman HA. Des-gamma-carboxy(abnormal) prothrombin and hepatocellular carcinoma: A critical review. Hepatology 1993;18: 990-7.
6. Tsai SL, Huang GT, Yang PM, et al. Des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology 1990;11: 481-8.
7. Liebman HA, Furie BC, Tong MJ, et al. Des-gamma-carboxy(abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427-31.
8. Motohara K, Kuroki Y, Kan H, et al. Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res 1985;19:354-7.
9. Naraki T, Watanabe K, Shimazuru Y, et al. Development and evaluation of the EIA kit for detection of PIVKA-II using double antibody sandwich system: monoclonal antibody to PIVKA-II and polyclonal antibody to prothrombin. Clin Immunol 1986;18:479-92.
10. Fujiyama S, Morishita T, Hashiguchi O, et al. Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 1988;61:1621-8.
11. Tanabe Y, Ohnishi K, Nomura F, et al. Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma. Am J Gastroenterol 1988;83:1386-9.
12. Kasahara A, Hayashi N, Fusamoto H, et al. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes. Dig Dis Sci 1991;38:2170-6.
13. Guesdon JL, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979; 27:1131-9.
14. Zweig MH, Campbell G. Receiver-operating characteristic(ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
15. Fujiyama S, Motohara T, Sagara K, et al. Clinical evaluation of plasma prothrombin (PIVKA-II) in patients with hepatocellular carcinoma. Hepatogastroenterology 1986;33:201-5.
16. Okuda H, Obata H, Nakanishi T, et al. Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. J Hepatol 1987;4:357-63.
17. Saitoh S, Ikeda K, Koida I, et al. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas. Cancer 1994;74:2918-23.
18. Aoyagi Y, Suzuki Y, Isemura M, et al. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988;61:769-74.
19. Taketa K, Sekiya C, Namiki M, et al. Lectin-reactive profiles of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma and related conditions. Gastroenterology 1990;99: 508-18.